Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
39,817,308
-
Total 13F shares
-
660,884
-
Share change
-
-142,278
-
Total reported value
-
$1,502,744
-
Price per share
-
$2.20
-
Number of holders
-
19
-
Value change
-
-$141,291
-
Number of buys
-
9
-
Number of sells
-
11
Institutional Holders of MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) as of Q1 2024
As of 31 Mar 2024,
MAIA Biotechnology, Inc. - Common Stock, $0.0001 par value (MAIA) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
660,884 shares.
The largest 10 holders included
VANGUARD GROUP INC, Centric Wealth Management, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Virtu Financial LLC, JANE STREET GROUP, LLC, CITADEL ADVISORS LLC, Naviter Wealth, LLC, STATE STREET CORP, and NORTHERN TRUST CORP.
This page lists
19
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.